Oxford BioMedica provided capital expenditure guidance for the year 2015/2016. For the year, the company expected capital expenditure to be in the range of £20 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
327 GBX | -2.24% | +1.08% | +48.64% |
09/05 | Avon Protection wins UK MoD supply deal; Molten Ventures up | AN |
09/05 | Molten Ventures wins UK MoD supply contract | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.64% | 417M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- OXB Stock
- News Oxford Biomedica plc
- Oxford BioMedica Provides Capital Expenditure Guidance for the Year 2015/2016